Comerica Bank Merck & Co., Inc. Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Merck & Co., Inc. stock. As of the latest transaction made, Comerica Bank holds 1,104,917 shares of MRK stock, worth $109 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

1,104,917

Previous 1,102,025 0.26%

Holding current value

$109 Million

Previous $136 Million 8.03%

% of portfolio

0.5%

Previous 0.57%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $321,445 - $372,981	2,892 Added 0.26%	1,104,917 $125 Million
Q2 2024 Aug 15, 2024	SELL	$123.8 - $132.96 $71,556 - $76,850	-578 Reduced 0.05%	1,102,025 $136 Million
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $2.01 Million - $2.34 Million	-17,740 Reduced 1.58%	1,102,603 $145 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $2 Million - $2.18 Million	-19,953 Reduced 1.75%	1,120,343 $122 Million
Q3 2023 Nov 21, 2023	SELL	$102.95 - $114.33 $233 Million - $259 Million	-2,262,207 Reduced 66.49%	1,140,296 $117 Million
Q2 2023 Aug 22, 2023	BUY	$108.61 - $118.38 $293 Million - $319 Million	2,698,467 Added 383.29%	3,402,503 $290,000
Q4 2022 Jan 26, 2023	BUY	$87.44 - $112.11 $214,840 - $275,454	2,457 Added 0.35%	704,036 $0
Q3 2022 Oct 28, 2022	BUY	$84.53 - $94.96 $282,414 - $317,261	3,341 Added 0.48%	701,579 $68.3 Million
Q2 2022 Aug 02, 2022	SELL	$83.49 - $94.64 $1.26 Million - $1.43 Million	-15,147 Reduced 2.12%	698,238 $64.5 Million
Q1 2022 Apr 27, 2022	BUY	$73.51 - $82.4 $257,652 - $288,812	3,505 Added 0.49%	713,385 $58.5 Million
Q4 2021 Feb 18, 2022	SELL	$72.28 - $90.54 $1.86 Million - $2.33 Million	-25,787 Reduced 3.51%	709,880 $54.4 Million
Q3 2021 Nov 22, 2021	SELL	$71.68 - $78.83 $9.54 Million - $10.5 Million	-133,130 Reduced 15.32%	735,667 $55.3 Million
Q2 2021 Aug 26, 2021	SELL	$70.31 - $77.77 $168,744 - $186,648	-2,400 Reduced 0.28%	868,797 $67.6 Million
Q1 2021 Apr 28, 2021	SELL	$68.86 - $81.11 $753,328 - $887,343	-10,940 Reduced 1.24%	871,197 $64.1 Million
Q4 2020 Jan 28, 2021	SELL	$71.77 - $79.65 $1.88 Million - $2.09 Million	-26,224 Reduced 2.89%	882,137 $68.9 Million
Q3 2020 Oct 30, 2020	BUY	$73.18 - $82.95 $815,957 - $924,892	11,150 Added 1.24%	908,361 $71.9 Million
Q2 2020 Jul 31, 2020	SELL	$70.42 - $80.13 $138,304 - $157,375	-1,964 Reduced 0.22%	897,211 $66.2 Million
Q1 2020 May 01, 2020	SELL	$63.36 - $87.82 $1.03 Million - $1.43 Million	-16,241 Reduced 1.77%	899,175 $66 Million
Q4 2019 Feb 07, 2020	SELL	$77.58 - $87.54 $2.17 Million - $2.45 Million	-27,996 Reduced 2.97%	915,416 $79.4 Million
Q3 2019 Oct 31, 2019	BUY	$76.08 - $82.93 $425,895 - $464,242	5,598 Added 0.6%	943,412 $75.8 Million
Q2 2019 Aug 02, 2019	SELL	$69.84 - $81.59 $6.99 Million - $8.17 Million	-100,092 Reduced 9.64%	937,814 $0
Q1 2019 May 02, 2019	SELL	$69.58 - $79.36 $2.43 Million - $2.77 Million	-34,875 Reduced 3.25%	1,037,906 $0
Q4 2018 Feb 06, 2019	SELL	$65.24 - $75.71 $2.7 Million - $3.13 Million	-41,359 Reduced 3.71%	1,072,781 $78.6 Million
Q3 2018 Nov 01, 2018	SELL	$57.69 - $67.84 $9.84 Million - $11.6 Million	-170,503 Reduced 13.27%	1,114,140 $80.3 Million
Q2 2018 Aug 01, 2018	SELL	$50.83 - $59.72 $2.34 Million - $2.75 Million	-45,975 Reduced 3.46%	1,284,643 $80.3 Million
Q1 2018 May 01, 2018	SELL	$50.96 - $59.23 $824,736 - $958,578	-16,184 Reduced 1.2%	1,330,618 $78 Million
Q4 2017 Feb 02, 2018	SELL	$51.62 - $61.64 $3.16 Million - $3.77 Million	-61,182 Reduced 4.35%	1,346,802 $82.4 Million
Q3 2017 Nov 06, 2017	BUY	$58.67 - $63.13 $82.6 Million - $88.9 Million	1,407,984	1,407,984 $77 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $249B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account